Suchergebnisse - "LaVange, Lisa M"

PubPharm (87)

41

Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS)

enthalten in: Thorax | 2014

von Couper, D. | LaVange, L. | Han, M. | +32

42

The Role of Statistics in Regulatory Decision Making

enthalten in: Therapeutic innovation & regulatory science | 2014

von LaVange, L.

43

Bayesian approach to the design and analysis of non-inferiority trials for anti-infective products

enthalten in: Pharmaceutical statistics | 2014

von Gamalo, M. | Tiwari, R. | LaVange, L.

44

Bayesian approach to the design and analysis of non‐inferiority trials for anti‐infective products

enthalten in: Pharmaceutical statistics | 2014

von Gamalo, M. | Tiwari, R. | LaVange, L.

45

The Role of Statistics in Regulatory Decision Making

enthalten in: Therapeutic innovation & regulatory science | 2014

von LaVange, L.

46

The Role of Statistics in Regulatory Decision Making

enthalten in: Therapeutic innovation & regulatory science | 2014

von LaVange, L.

47

The Role of Statistics in Regulatory Decision Making

enthalten in: Therapeutic innovation & regulatory science | 2014

von LaVange, L.

48

The Role of Statistics in Regulatory Decision Making

enthalten in: Therapeutic innovation & regulatory science | 2014

von LaVange, L.

49

Standardizing nasal nitric oxide measurement as a test for primary ciliary dyskinesia

enthalten in: Annals of the American Thoracic Society | 2013

von Leigh, M. | Hazucha, M. | Chawla, K. | +19

CommentIn: Ann Am Thorac Soc. 2013 Dec;10(6):645-7. - PMID 24364768

50

Cancer incidence among those initiating insulin therapy with glargine versus human NPH insulin

enthalten in: Diabetes care | 2013

von Stürmer, T. | Marquis, M. | Zhou, H. | +8